LBBW Aktienanleihe OMV 28.04.2025/ DE000LB46CP7 /
26/09/2024 17:15:09 | Chg.-0.430 | Bid09:08:45 | Ask09:08:45 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
95.150EUR | -0.45% | 95.670 Bid Size: 250,000 |
95.870 Ask Size: 250,000 |
OMV AG | 38.01 EUR | 28/04/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center